文献速递胸部肿瘤

亚洲女性从不吸烟者低剂量计算机断层扫描(LDCT)肺癌筛查检出肺癌效能与亚洲男性曾吸烟者相当:系统评价与Meta分析

Low-Dose Computed Tomography (LDCT) Lung Cancer Screening in Asian Female Never-Smokers Is as Efficacious in Detecting Lung Cancer as in Asian Male Ever-Smokers: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Thorac Oncol · 2023-02-10

该系统评价与Meta分析纳入14项同时包含曾吸烟者与从不吸烟者的LDCT肺癌筛查研究(13项来自亚洲),比较两组肺癌检出相对风险。从不吸烟者与曾吸烟者总体肺癌检出RR为1.21(95%CI 0.89-1.65),从不吸烟者肺癌死亡RR为0.27(95%CI 0.1-0.55),5年全因死亡RR为0.13(95%CI 0.05-0.33)。

要点

  • 从不吸烟者与曾吸烟者总体肺癌检出RR为1.21(95%CI 0.89-1.65),无统计学显著差异。
  • 从不吸烟者首次扫描诊断肺癌比例为95.4%,曾吸烟者为70.9%(p=0.010)。
  • 从不吸烟者肺癌死亡RR为0.27(95%CI 0.1-0.55,p<0.001)。

核心结论

  • 亚洲女性从不吸烟者与男性曾吸烟者经LDCT筛查检出的肺癌相对风险在统计学上相似。
  • 从不吸烟者经LDCT筛查诊断肺癌后的总体死亡和肺癌特异性死亡较曾吸烟者显著降低。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed和Scopus至2021年4月30日发表的LDCT肺癌筛查研究。
  • 纳入同时包含曾吸烟者和从不吸烟者参与者的研究,共14项(13项来自亚洲),合计141,396名曾吸烟者、109,251名从不吸烟者、1961例肺癌诊断。
  • 主要结局指标为从不吸烟者 versus 曾吸烟者诊断肺癌的相对风险(RR)。

主要发现

  • 曾吸烟者 versus 从不吸烟者总体肺癌诊断RR为1.21(95%CI 0.89-1.65)。
  • 男性中曾吸烟者 versus 从不吸烟者肺癌诊断RR为1.37(95%CI 1.08-1.75),女性中为0.88(95%CI 0.59-1.31)。
  • 亚洲女性从不吸烟者 versus 男性从不吸烟者肺癌诊断RR为1.78(95%CI 1.41-2.24), versus 男性曾吸烟者为1.22(95%CI 0.89-1.68), versus 高危曾吸烟者(≥30包年)为0.99(95%CI 0.65-1.50)。
  • 从不吸烟者 versus 曾吸烟者首次扫描诊断肺癌比例为95.4%(95%CI 84.9-100.0) versus 70.9%(95%CI 54.6-84.9),p=0.010;1期诊断比例为88.5%(95%CI 79.3-95.4) versus 79.7%(95%CI 71.1-87.4),p=0.071。
  • 从不吸烟者 versus 曾吸烟者肺癌死亡RR为0.27(95%CI 0.1-0.55,p<0.001),5年全因死亡RR为0.13(95%CI 0.05-0.33,p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Lung cancer in never-smokers is the major cancer cause of death globally. We compared the efficacy of low-dose computed tomography (LDCT) lung cancer screening among never-smokers versus ever-smokers using systematic review and meta-analysis. METHODS: LDCT lung cancer screening studies that simultaneously included both ever-smoker and never-smoker participants published by April 30, 2021, were searched through PubMed and Scopus. Primary outcome measure was relative risk (RR) of lung cancer diagnosed among never-smokers versus ever-smokers. RESULTS: A total of 14 studies (13 from Asia) were included (141,396 ever-smokers, 109,251 never-smokers, 1961 lung cancer cases diagnosed). RR of lung cancer diagnosed between ever-smokers versus never-smokers overall was 1.21 (95% confidence interval [CI]: 0.89-1.65), 1.37 (95% CI: 1.08-1.75) among males, and 0.88 (95% CI: 0.59-1.31) among females. RR was 1.78 (95% CI: 1.41-2.24) and 1.22 (95% CI: 0.89-1.68) for Asian female never-smokers versus male never-smokers and versus male ever-smokers, respectively, and 0.99 (95% CI: 0.65-1.50) versus high-risk ever-smokers (≥30 pack-years). Proportional meta-analysis revealed significantly more lung cancers diagnosed at first scan (95.4% [95% CI: 84.9-100.0] versus 70.9% [95% CI: 54.6-84.9], p = 0.010) and at stage 1 (88.5% [95% CI: 79.3-95.4] versus 79.7% [95% CI: 71.1-87.4], p = 0.071) among never-smokers versus ever-smokers, respectively. RR of lung cancer death and 5-year all-cause mortality in never-smokers versus ever-smokers was 0.27 (95% CI: 0.1-0.55, p < 0.001) and 0.13 (95% CI: 0.05-0.33, p < 0.001), respectively. CONCLUSIONS: The RR of lung cancer detected by LDCT screening among female never-smokers and male ever-smokers in Asia was statistically similar. Overall and lung cancer specific mortality from the lung cancer diagnosed from LDCT screening was significantly reduced among never-smokers compared to ever-smokers.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Triphuridet N, Zhang SS, Nagasaka M, et al. Low-Dose Computed Tomography (LDCT) Lung Cancer Screening in Asian Female Never-Smokers Is as Efficacious in Detecting Lung Cancer as in Asian Male Ever-Smokers: A Systematic Review and Meta-Analysis. J Thorac Oncol. 2023. PMID: 36775191. doi:10.1016/j.jtho.2023.01.094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。